drugset

drugset / Trial / NCT00152373

Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS

NCT00152373 ↗

Phase 3 Completed 192 enrolled UCB Pharma

RandomizedParallel-groupDouble-blind

Summary

clinical efficacy and safety of Levetiracetam as add-on therapy in adult Chinese subjects with partial seizures.

Timeline

Start: 2004-07
Primary completion: 2005-05
Completion: 2005-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Levetiracetam	Other / unclassified	—	—

Indications